XATMEP
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 16 Mar 2024)
What this means for you
Registered since 31 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86934766
- Registration number
- 5324671
- Mark type
- Stylized text
- Filed
- 09 Mar 2016
- Published for opposition
- 02 Aug 2016
- Registered
- 31 Oct 2017
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders
Owner
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- Argentum Holdings, LLC, Woburn, MA, US
- Argentum Holdings, LLC, Palo Alto, CA, US
- Argentum Holdings, LLC, Palo Alto, CA, US
Prosecution history
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 19 Mar 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Mar 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 16 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jan 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 31 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 26 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Sept 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Aug 2017 — USE AMENDMENT FILED